NIH #2R01CA137008-06
Impact of heterogeneity on response to EGFR T790M inhibitors
- Amount
- $406K
- Period
- 2009-03-01 → 2020-03-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at MASSACHUSETTS GENERAL HOSPITAL
NIH #5R01CA140594-06
Therapeutic strategies for specific subsets of KRAS mutant lung cancers
- Amount
- $497K
- Period
- 2009-08-03 → 2018-03-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at DANA-FARBER CANCER INST
NIH #2R01CA140594-05
Therapeutic strategies for specific subsets of KRAS mutant lung cancers
- Amount
- $531K
- Period
- 2009-08-03 → 2018-03-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at DANA-FARBER CANCER INST
NIH #5R01CA164273-03
Identification of Resistance Mechanisms to Anaplastic Lymphoma Kinase Inhibitors
- Amount
- $341K
- Period
- 2012-02-20 → 2016-12-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at MASSACHUSETTS GENERAL HOSPITAL
NIH #5R01CA164273-02
Identification of Resistance Mechanisms to Anaplastic Lymphoma Kinase Inhibitors
- Amount
- $331K
- Period
- 2012-02-20 → 2016-12-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at MASSACHUSETTS GENERAL HOSPITAL
NIH #1R01CA164273-01
Identification of Resistance Mechanisms to Anaplastic Lymphoma Kinase Inhibitors
- Amount
- $353K
- Period
- 2012-02-20 → 2016-12-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at MASSACHUSETTS GENERAL HOSPITAL
NIH #5R01CA140594-07
Therapeutic strategies for specific subsets of KRAS mutant lung cancers
- Amount
- $512K
- Period
- 2009-08-03 → 2016-03-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at DANA-FARBER CANCER INST
NIH #5R01CA164273-04
Identification of Resistance Mechanisms to Anaplastic Lymphoma Kinase Inhibitors
- Amount
- $352K
- Period
- 2012-02-20 → 2015-12-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at MASSACHUSETTS GENERAL HOSPITAL
NIH #5R01CA137008-05
The Activation of ERBB3 Signaling as a Resistance Mechanism to Targeted Therapies
- Amount
- $321K
- Period
- 2009-03-01 → 2015-03-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at MASSACHUSETTS GENERAL HOSPITAL
NIH #5R01CA137008-04
The Activation of ERBB3 Signaling as a Resistance Mechanism to Targeted Therapies
- Amount
- $341K
- Period
- 2009-03-01 → 2013-12-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at MASSACHUSETTS GENERAL HOSPITAL
NIH #5R01CA137008-03
The Activation of ERBB3 Signaling as a Resistance Mechanism to Targeted Therapies
- Amount
- $341K
- Period
- 2009-03-01 → 2013-12-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at MASSACHUSETTS GENERAL HOSPITAL
NIH #5R01CA137008-02
The Activation of ERBB3 Signaling as a Resistance Mechanism to Targeted Therapies
- Amount
- $352K
- Period
- 2009-03-01 → 2013-12-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at MASSACHUSETTS GENERAL HOSPITAL
NIH #1R01CA137008-01
The Activation of ERBB3 Signaling as a Resistance Mechanism to Targeted Therapies
- Amount
- $370K
- Period
- 2009-03-01 → 2013-12-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at MASSACHUSETTS GENERAL HOSPITAL
NIH #4R01CA140594-03
Inhibition of P13k and MEK Pathways in the Treatment of Lung Cancer
- Amount
- $497K
- Period
- 2009-08-03 → 2013-06-30
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at DANA-FARBER CANCER INST
NIH #5R01CA140594-04
Inhibition of P13k and MEK Pathways in the Treatment of Lung Cancer
- Amount
- $496K
- Period
- 2009-08-03 → 2013-03-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at DANA-FARBER CANCER INST
NIH #5R01CA140594-02
Inhibition of P13k and MEK Pathways in the Treatment of Lung Cancer
- Amount
- $476K
- Period
- 2009-08-03 → 2011-06-30
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at DANA-FARBER CANCER INST
NIH #1R01CA140594-01
Inhibition of P13k and MEK Pathways in the Treatment of Lung Cancer
- Amount
- $434K
- Period
- 2009-08-03 → 2011-06-30
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at DANA-FARBER CANCER INST
NIH #5K08CA120060-05
Molecular mechanisms of PI3K activation in non-small cell lung cancer
- Amount
- $144K
- Period
- 2006-04-05 → 2011-03-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at MASSACHUSETTS GENERAL HOSPITAL
NIH #5K08CA120060-04
Molecular mechanisms of PI3K activation in non-small cell lung cancer
- Amount
- $143K
- Period
- 2006-04-05 → 2011-03-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at MASSACHUSETTS GENERAL HOSPITAL
NIH #5K08CA120060-03
Molecular mechanisms of PI3K activation in non-small cell lung cancer
- Amount
- $142K
- Period
- 2006-04-05 → 2011-03-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at MASSACHUSETTS GENERAL HOSPITAL
NIH #5K08CA120060-02
Molecular mechanisms of PI3K activation in non-small cell lung cancer
- Amount
- $141K
- Period
- 2006-04-05 → 2011-03-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at MASSACHUSETTS GENERAL HOSPITAL
NIH #1K08CA120060-01
Molecular mechanisms of PI3K activation in non-small cell lung cancer
- Amount
- $140K
- Period
- 2006-04-05 → 2011-03-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at MASSACHUSETTS GENERAL HOSPITAL